Luis de la Cruz-Merino-rekin lankidetzan egindako argitalpenak (7)

2024

  1. A genetic profiling guideline to support diagnosis and clinical management of lymphomas

    Clinical and Translational Oncology, Vol. 26, Núm. 5, pp. 1043-1062

2019

  1. Efficacy of the combination of rituximab-bendamustine as a second-line treatment in patients with follicular lymphoma who progress after immunochemotherapy: a phase II trial of the Spanish Lymphoma Oncology Group

    Leukemia and Lymphoma

  2. Transformed follicular lymphoma in the rituximab era: A report from the Spanish Lymphoma Oncology Group

    Hematological Oncology, Vol. 37, Núm. 2, pp. 143-150

  3. Unraveling transformation of follicular lymphoma to diffuse large B-cell lymphoma

    PLoS ONE, Vol. 14, Núm. 2

2017

  1. Prognostic value of event-free survival at 12 and 24 months and long-term mortality for non-Hodgkin follicular lymphoma patients: A study report from the Spanish Lymphoma Oncology Group

    Cancer, Vol. 123, Núm. 19, pp. 3709-3716

2015

  1. SEOM clinical guidelines for the treatment of Hodgkin’s lymphoma

    Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 1005-1013

  2. SEOM clinical guidelines for the treatment of follicular non-Hodgkin’s lymphoma

    Clinical and Translational Oncology, Vol. 17, Núm. 12, pp. 1014-1019